|
|
||||||||
Department of Physiology, Monash University, Clayton, Victoria, Australia.
1. Neuropeptide Y caused a dose-dependent contraction and depolarization of the smooth muscle of the rat tail artery. 2. 30 nM-neuropeptide Y increased the contraction caused by either nerve-released noradrenaline or smooth muscle action potentials. 3. 30 nM-neuropeptide Y did not change the amplitude or rate of rise of the smooth muscle action potential. It did not change the amplitude of small excitatory junction potentials, suggesting that it did not affect neurotransmitter release. 4. 30 nM-neuropeptide Y increased the contraction caused by exogenous noradrenaline, 5-hydroxytryptamine and K in concentrations that gave submaximal contractions. It did not affect the response to higher concentrations that gave maximal or near-maximal contractions.
This article has been cited by other articles:
![]() |
D. N. Jackson, K. J. Milne, E. G. Noble, and J. K. Shoemaker Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats J. Physiol., January 1, 2005; 562(1): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bradley, A. Law, D. Bell, and C. D. Johnson Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2007 - H2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Heath Neuropeptide Y and Y1-receptor agonists increase blood flow through arteriovenous anastomoses in rat tail J Appl Physiol, July 1, 1998; 85(1): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |